Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 28(15): 1748-58, 2009 Apr 16.
Article in English | MEDLINE | ID: mdl-19270727

ABSTRACT

Mitotic microtubule (MT)-targeting drugs are widely used to treat cancer. The GTPase Ran regulates multiple processes, including mitotic spindle assembly, spindle pole formation and MT dynamics; Ran activity is therefore essential to formation of a functional mitotic apparatus. The RanBP1 protein, which binds Ran and regulates its interaction with effectors, is overexpressed in many cancer types. Several observations indicate that RanBP1 contributes to regulate the function of the mitotic apparatus: RanBP1 inactivation yields hyperstable MTs and induces apoptosis during mitosis, reminiscent of the effects of the MT-stabilizing drug taxol. Here we have investigated the influence of RanBP1 on spontaneous and taxol-induced apoptosis in transformed cells. We report that RanBP1 downregulation by RNA interference activates apoptosis in several transformed cell lines regardless of their p53 status, but not in the caspase-3-defective MCF-7 breast cancer cell line. Furthermore, RanBP1-interfered cells show an increased apoptotic response to taxol compared to their counterpart with normal or high RanBP1 levels, and this response is caspase-3 dependent. These results indicate that RanBP1 can modulate the outcome of MT-targeting therapeutic protocols.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Caspase 3/physiology , Nuclear Proteins/physiology , Paclitaxel/pharmacology , Apoptosis , Cell Line, Tumor , Down-Regulation , HeLa Cells , Humans , Microtubules/drug effects , Nuclear Proteins/antagonists & inhibitors , Tumor Suppressor Protein p53/physiology
2.
Cell Mol Life Sci ; 64(15): 1891-914, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17483873

ABSTRACT

Mitosis is the most potentially dangerous event in the life of a cell, during which the cell genetic identity is transmitted to daughters; errors at this stage may yield aneuploid cells that can initiate a genetically unstable clone. The small GTPase Ran is the central element of a conserved signaling network that has a prominent role in mitotic regulation. Pioneering studies with amphibian oocytes indicated that Ran, in the GTP-bound form, activates factors that regulate spindle assembly and dynamics. An increasing body of data indicate higher specificity and complexity in mitotic control operated by Ran in somatic cells. Newly identified target factors of Ran operate with different specificity, and it is emerging that mitotic progression requires the precise positioning of Ran network components and effectors at specific sites of the mitotic apparatus according to a highly regulated schedule in space and time. In this review we summarize our current understanding of Ran control of mitosis and highlight the specificity of mechanisms operating in mammalian somatic cells.


Subject(s)
Mitosis/physiology , ran GTP-Binding Protein/physiology , Animals , Biological Transport, Active , Cell Cycle/physiology , Centrosome/physiology , Humans , Interphase/physiology , Microtubules/physiology , Models, Biological , Spindle Apparatus/physiology
3.
Mol Biol Cell ; 15(8): 3751-7, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15181149

ABSTRACT

We recently demonstrated that the p53 oncosuppressor associates to centrosomes in mitosis and this association is disrupted by treatments with microtubule-depolymerizing agents. Here, we show that ATM, an upstream activator of p53 after DNA damage, is essential for p53 centrosomal localization and is required for the activation of the postmitotic checkpoint after spindle disruption. In mitosis, p53 failed to associate with centrosomes in two ATM-deficient, ataxiatelangiectasia-derived cell lines. Wild-type ATM gene transfer reestablished the centrosomal localization of p53 in these cells. Furthermore, wild-type p53 protein, but not the p53-S15A mutant, not phosphorylatable by ATM, localized at centrosomes when expressed in p53-null K562 cells. Finally, Ser15 phosphorylation of endogenous p53 was detected at centrosomes upon treatment with phosphatase inhibitors, suggesting that a p53 dephosphorylation step at centrosome contributes to sustain the cell cycle program in cells with normal mitotic spindles. When dissociated from centrosomes by treatments with spindle inhibitors, p53 remained phosphorylated at Ser15. AT cells, which are unable to phosphorylate p53, did not undergo postmitotic proliferation arrest after nocodazole block and release. These data demonstrate that ATM is required for p53 localization at centrosome and support the existence of a surveillance mechanism for inhibiting DNA reduplication downstream of the spindle assembly checkpoint


Subject(s)
Centrosome/chemistry , Mitosis , Protein Serine-Threonine Kinases/metabolism , Serine/metabolism , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Protein p53/metabolism , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins , Cell Line , Centrosome/metabolism , DNA-Binding Proteins , Humans , Mutation/genetics , Nocodazole/pharmacology , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/genetics , Serine/genetics , Spindle Apparatus/drug effects , Spindle Apparatus/metabolism , Tubulin/analysis , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Proteins
4.
J Biol Chem ; 276(22): 19205-13, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11376010

ABSTRACT

Growing evidence indicates a central role for p53 in mediating cell cycle arrest in response to mitotic spindle defects so as to prevent rereplication in cells in which the mitotic division has failed. Here we report that a transient inhibition of spindle assembly induced by nocodazole, a tubulin-depolymerizing drug, triggers a stable activation of p53, which can transduce a cell cycle inhibitory signal even when the spindle-damaging agent is removed and the spindle is allowed to reassemble. Cells transiently exposed to nocodazole continue to express high levels of p53 and p21 in the cell cycle that follows the transient exposure to nocodazole and become arrested in G(1), regardless of whether they carry a diploid or polyploid genome after mitotic exit. We also show that p53 normally associates with centrosomes in mitotic cells, whereas nocodazole disrupts this association. Together these results suggest that the induction of spindle damage, albeit transient, interferes with the subcellular localization of p53 at specific mitotic locations, which in turn dictates cell cycle arrest in the offspring of such defective mitoses.


Subject(s)
Centrosome/metabolism , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/metabolism , Anaphase , Antineoplastic Agents/pharmacology , Blotting, Western , Cell Cycle , Cell Line , Cell Separation , Flow Cytometry , Fluorescent Antibody Technique, Indirect , G1 Phase , Humans , K562 Cells , Metaphase , Microscopy, Fluorescence , Mitosis , Nocodazole/pharmacology , Ploidies , Proto-Oncogene Proteins p21(ras)/metabolism , Time Factors , Transfection , Tubulin/metabolism , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...